Cuentas Inc. Common Stock
CUEN
CUEN was delisted on the 19th of December, 2023.
7 hedge funds and large institutions have $331K invested in Cuentas Inc. Common Stock in 2023 Q2 according to their latest regulatory filings, with 0 funds opening new positions, 2 increasing their positions, 1 reducing their positions, and 3 closing their positions.
100% more repeat investments, than reductions
Existing positions increased: 2 | Existing positions reduced: 1
30% less funds holding
Funds holding: 10 → 7 (-3)
71% less capital invested
Capital invested by funds: $1.14M → $331K (-$809K)
100% less first-time investments, than exits
New positions opened: 0 | Existing positions closed: 3
Top Buyers
| 1 |
TRCT
Tower Research Capital (TRC)
New York
|
+$2.21K |
| 2 |
Wells Fargo
San Francisco,
California
|
+$14 |
Top Sellers
| 1 |
AC
Armistice Capital
New York
|
-$662K |
| 2 |
Renaissance Technologies
New York
|
-$58K |
| 3 |
APC
Aspire Private Capital
Cornelius,
North Carolina
|
-$1.34K |
CUEN Hedge Fund Activity: Q2 2023 in Review
7 of the 6,369 institutional investors tracked by Wall St. Rank reported a position in Cuentas Inc. Common Stock (CUEN) for Q2 2023, worth a combined $331K — down 71% from $1.14M a quarter earlier.
Sellers outnumbered buyers: 3 funds closed out of CUEN and 0 opened new positions — a net loss of 3 holders — while 1 trimmed existing stakes and 2 added.
The largest buyer was Tower Research Capital (TRC), adding an estimated $2.21K. The largest seller was Armistice Capital, exiting entirely with an estimated $662K sold.
- 7 institutional investors held Cuentas Inc. Common Stock (CUEN) as of Q2 2023, down from 10 in Q1 2023.
- Funds reported $331K of Cuentas Inc. Common Stock stock for Q2 2023, down 71% quarter-over-quarter.
- 0 funds opened new Cuentas Inc. Common Stock positions in Q2 2023 and 3 closed out, a net change of -3 holders.
- The largest Cuentas Inc. Common Stock buyer in Q2 2023 was Tower Research Capital (TRC), an estimated $2.21K added.
- The largest Cuentas Inc. Common Stock seller in Q2 2023 was Armistice Capital, an estimated $662K sold.
Based on aggregated 13F filings for Q2 2023.